Photodynamic Therapy Is More Effective Than Imiquimod for Actinic Keratosis in Organ Transplant Recipients - A Randomized Intra-Individual Controlled Trial

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.15884
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Local Interventions for Actinic Keratosis in Organ Transplant Recipients: A Systematic Review

British Journal of Dermatology
DermatologyMedicine
2018English

Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2016English

A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients

Nephron
MedicineUrologyPhysiologyNephrology
2016English

Imiquimod 5% Cream for the Treatment of Actinic Keratosis of the Eyelid

Beyoglu Eye Journal
2017English

Improving Outcomes of Renal Transplant Recipients With Behavioral Adherence Contracts: A Randomized Controlled Trial

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2013English

Clinical Utility of Daylight Photodynamic Therapy in the Treatment of Actinic Keratosis – A Review of the Literature

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2019English

Verapamil Is Less Effective Than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Tai Chi Is Effective in Treating Knee Osteoarthritis: A Randomized Controlled Trial

Arthritis & Rheumatism
2009English

Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod and Topical 5-Fluorouracil in Patients With Superficial Basal Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy